Annaly Capital Q2 EPS rises sharply as securization activity hits record
Annaly Capital Q2 EPS rises sharply as securization activity hits record
Overview
U.S. mortgage REIT's Q2 GAAP EPS rose sharply year-over-year
Earnings available for distribution per share increased from prior year
Company raised quarterly dividend to $0.75 per share
Outlook
Annaly sees meaningful opportunities across all three investment strategies
Company says scale, liquidity and disciplined capital allocation position it for risk-adjusted returns
Result Drivers
AGENCY PORTFOLIO GROWTH - Co increased Agency portfolio by nearly $3 bln, focusing on higher coupon TBA securities and specified pools
SECURITIZATION ACTIVITY - Record thirteen securitizations totaling $6.8 bln issued by Residential Credit Group, expanding financing capacity
HIGH HEDGE RATIO - Maintained conservative hedge positioning with a 97% hedge ratio due to elevated macro uncertainty
Company press release: ID:nBw9W3ZTqa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 EPS |
| $1.06 |
|
Reuters Recommended Reads
July 20 - AGNC Investment Q2 net spread income slips on lower asset yields
July 20 - Dynex Capital Q2 book value rises as portfolio expands
July 21 - Equifax sees downbeat annual revenue amid tough mortgage market
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Annaly Capital Management
See all newsUS RESEARCH ROUNDUP-3M, Constellation Energy, Metropolitan Bank
Annaly Capital Management, Inc. reports results for the quarter ended September 30 - Earnings Summary
Annaly Capital posts Q3 net loss amid challenging fixed-income markets
Annaly Capital Management, Inc. expected to post earnings of 77 cents a share - Earnings Preview
US RESEARCH ROUNDUP-Allstate, Caribou Biosciences, Zscaler